Global Immunoglobulin Products Market 2016-2020

Global immunoglobulin products market outlook

According to the immunoglobulin products industry insights, Technavio’s market research analyst has estimated that this market will grow at a CAGR of almost 7% during the estimated period. The recent approval of immunoglobulins to treat neuroimmunological disorders is a noteworthy factor that will impel the prospects for the growth of immunoglobulin products market size until the end of the forecast period. Recently, immunoglobulin products were approved for the treatment of neuroimmunological disorders like multifocal motor neuropathy, Alzheimer's disease, and Guillain-Barré syndrome.  Due to its widespread applicability, immunoglobulin products that are utilized for the treatment of neuroimmunological disorders are anticipated to contribute the largest proportion of revenue to the global immunoglobulin products market in the next few years. Immunoglobulin products used for the treatment of primary immunodeficiency disease (PID) and neuroimmunological disorders account for around 90% of the total market revenue.

In terms of geography, the Americas will be the largest market for immunoglobulin products during the forecast period and will generate revenues of nearly USD 9 billion by the end of 2020. The high incidence of PID and other autoimmune diseases in the US and Canada is a major factor that will spur the prospects for market growth until 2020. In addition, factors such as the affordability of therapies due to the presence of well-structured reimbursement plans will also augment market growth in the Americas during the next four years.

Segmentation by type and analysis of the immunoglobulin products market

• IgA
• IgG
• IgM
• IgD
• IgE

In 2015, the global immunoglobulin products market was dominated by the IgG segment, which accounted for approximately 77% of the total market share. IgGs are the smallest antibodies and account for nearly 75%-80% of all the antibodies in the body. The ability of these antibodies to fight against bacterial and viral infections will lead to its increased adoption during the forecast period.

Segmentation by ROA and analysis of the immunoglobulin products market

• IMIG products
• SCIG products
• IVIG products

The IVIG products segment accounted for around 60% of the total market share during 2015 and is anticipated to retain its hold over the market throughout the forecast period. Increasing global incidence of CIDP, hypogammaglobulinemia, and immunodeficiency diseases is a critical factor that will spur the prospects for growth in this market segment. In addition, the recent increase in prescriptions of IVIG to treat off-label indications such as Guillain–Barré syndrome, specific antibody deficiency, and inflammatory myopathies will also aid in the growth of this market segment over the next few years.

Competitive landscape and key vendors

The global immunoglobulin products market is growing at a significant pace because of the augmented demand for immunoglobulins, especially IVIG, to treat rare diseases. Though the leading players dominate this market, emerging players like Biotest and Bharat Biotech are likely to pose a threat to the established vendors in the market.

Top vendors in the market are 

• Baxalta
• CSL
• Grifols
• Biotest Pharmaceuticals
• Kedrion
• Octapharma

Other prominent vendors in this market are Abeona Therapeutics, Admabiologics, Anthera, Beijing Tiantan Biological Products (China), Bharat Serums and Vaccines (India), Bio Products Laboratory, China Biologic Products (China), Emergent Biosolutions, Gliknik, Greencross, Hansamedical, Hualan Biological Engineering (China), Immunomedics, Innate Pharma, Integrated Biotherapeutics, Janssen Pharmaceuticals, Kamada, LFB Group (France), Mitsubishi Tanabe Pharma, Momenta Pharma, Patrys, Shanghai RAAS Blood Products (China), Sichuan Yuanda Shuyang Pharmaceutical (China), and Sorrento Therapeutics.

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global immunoglobulin products market?
• What are the key market trends influencing the growth of the global immunoglobulin products market?
• What are the challenges to market growth?
• Who are the key vendors in the global immunoglobulin products market?
• What are the market opportunities and threats faced by the vendors in the global immunoglobulin products market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global immunoglobulin products market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

• Global Plasma Therapeutics Market 2015-2019
• Global Immunotherapy Drugs Market 2016-2020